Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives

DOI: 10.1590/abd1806-4841.20197938

Keywords: Keratosis, actinic, Face, Medication adherence, Patient compliance, Precancerous conditions, Skin neoplasms

Full-Text   Cite this paper   Add to My Lib

Abstract:

Actinic keratosis (AK) represents a risk of progression to squamous cell carcinoma. Ingenol mebutate gel is a novel therapeutic option for field-directed treatment

Full-Text